Business Models and Opportunities for Cancer Vaccine Developers

Human Vaccines and Immunotherapeutics - United States
doi 10.4161/hv.20629
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search